Status:
COMPLETED
Self-sampling for the Study of COVID-19
Lead Sponsor:
Medical College of Wisconsin
Conditions:
Coronavirus
Eligibility:
All Genders
18+ years
Brief Summary
This study will evaluate the feasibility of self-sampling with the iAMP® COVID-19 Detection Kit (Atila BioSystems, Mountain View, CA), a new, low-cost SARS-CoV-2 test that does not require RNA extract...
Detailed Description
3.1.1 Study population: The investigators will enroll patients within a larger clinical validation study of the iAMP® test against the gold standard (the CDC-recommended test) until we have prospectiv...
Eligibility Criteria
Inclusion
- Subjects older than 18 presenting for COVID-19 testing
- Subject able to tolerate nasopharyngeal swabs
- Subjects able to follow instructions for self-collection.
Exclusion
- Subjects younger than 18
- Subjects unable to tolerate nasopharyngeal swabs
- Subjects unable to follow instructions
- Subjects unable or unwilling to provide informed consent and/or reliable contact information.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT04447495
Start Date
July 1 2020
End Date
December 31 2020
Last Update
December 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mooreland Reserve Health Center
New Berlin, Wisconsin, United States, 53151